Evidence map›Paper›PMID 40217087›Full record

ArticleCell death and differentiation2025

Chronic skin and systemic inflammation modulated by S100A8 and S100A9 complexes.

Marta Palomo-Irigoyen, Latifa Bakiri, Tim Hendrikx, Silvia Hayer, Johanna Schaffenrath, Stefanie Widder, Sandra Bachg, Jared Simmons, Richard L Gallo, Philipp Starkl and 2 more

Abstract read
In one paragraph

Article in Cell death and differentiation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Deubiquitinase USP48 Promotes Gastric Cancer Peritoneal Metastasis by Stabilizing S100A9 to Drive Neutrophil Extracellular Traps Formation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marta Palomo-IrigoyenGenes and Disease Laboratory, Department of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2447-8343
Latifa BakiriGenes and Disease Laboratory, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-6300-2420
Tim HendrikxDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Silvia HayerDepartment of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Johanna SchaffenrathGenes and Disease Laboratory, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Stefanie WidderDivision of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Sandra BachgInstitute of Immunology, University of Münster, Münster, Germany.
Jared SimmonsDepartment of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA, USA.
Richard L GalloDepartment of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA, USA.
Philipp StarklDivision of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Johannes RothInstitute of Immunology, University of Münster, Münster, Germany.ORCID 0000-0001-7035-8348
Erwin F WagnerGenes and Disease Laboratory, Department of Dermatology, Medical University of Vienna, Vienna, Austria. erwin.wagner@meduniwien.ac.at.ORCID 0000-0001-7872-0196

Funding

Rheumatic Diseases Research Training GrantT32AR064194 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GARY S FIRESTEIN, Monica Guma · 2013 to 2026
$3.8M
EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERC AdG 2016-741888-CSI-FunEC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) H2020 Marie Skłodowska-Curie grant (ITN 2019-859860-CANCERPREV)NIAMS NIH HHS T32 AR064194
6 · The paper itself

Abstract

Increased expression of the homodimeric S100A8 (A8) and S100A9 (A9) alarmins and their Calprotectin (CP) antimicrobial hetero-complex has been reported in Inflammatory Skin Diseases (ISDs) such as Atopic Dermatitis (AD), but the functional consequences of this increase are not known. We evaluated the cell- and tissue-specific functions of A8 and A9 in the local and the extra-cutaneous manifestations of ISD using genetically engineered mouse models. The genes encoding for the A9 or A8 proteins were inactivated in epidermal cells or neutrophils in the JunB

Indexed as

Calgranulin ACalgranulin BDermatitis, AtopicInflammationSkinAnimalsCell DifferentiationChronic DiseaseDisease Models, AnimalMiceMice, Inbred C57BLMice, KnockoutNeutrophilsCalgranulin ACalgranulin BS100a8 protein, mouseS100A9 protein, mouse

Identifiers

PMID40217087
PMCPMC12501315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.